TI
IMDZ

Trexquant Investment’s Immune Design Corp. IMDZ Stock Holding History

Trexquant Investment’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,260
Closed -$148K – 1395
2017
Q3 		$148K Sell
14,260
-16,892
-54% -$166K 0.04% 693
2017
Q2 		$304K Buy
31,152
+4,174
+15% +$29.3K 0.08% 461
2017
Q1 		$183K Buy
+26,978
New +$156K 0.02% 978

Other funds holding IMDZ

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Trexquant Investment's IMDZ Position: Q4 2017 in Review

Trexquant Investment sold out of Immune Design Corp. (IMDZ) in Q4 2017, closing a stake of 14,260 shares — an estimated $148K sold.

Trexquant Investment first reported a position in IMDZ in Q1 2017 and held it in 3 quarters. The position peaked at $304K in Q2 2017. 76 funds tracked by Wall St. Rank hold IMDZ as of Q4 2017.

  • Trexquant Investment reported no remaining Immune Design Corp. position as of Q4 2017 after selling out during the quarter.
  • Trexquant Investment sold 14,260 Immune Design Corp. shares in Q4 2017, an estimated $148K.
  • Trexquant Investment first reported a position in Immune Design Corp. in Q1 2017 and held it in 3 quarters.
  • Trexquant Investment's Immune Design Corp. position peaked at $304K in Q2 2017.
  • 76 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2017.

Based on Trexquant Investment's 13F filing for Q4 2017, filed 9 Feb 2018.